BMY Bristol Myers Squibb Earnings and EPS analysis

EPS in 2025 (TTM): $2.68

Last Report Period Date: Mar 31, 2025

According to the most recent financial data from March 2025, the current EPS (TTM) is $2.68. Bristol Myers Squibb's EPS for 2024 came in at -$4.41, marking a decrease from $3.88 in 2023. For the quarterly period ending on Mar 31, 2025, BMY's EPS was $1.21.

BMY earnings history

Historical annual and quarterly earnings per share (EPS) data for Bristol Myers Squibb

EPS (TTM)

$2.68

EPS Growth YoY (Quarterly)

120.5%

EPS (Quarterly)

$1.21

EPS Growth (Quarterly)

2,925%

Bristol Myers Squibb had an annual EPS of -$4.41, marking a decrease of 213.7% from $3.88 in 2023. The quarterly EPS for the period ending Mar 31, 2025, was $1.21, marking a 120.5% increase from the same quarter last year. BMY's TTM EPS stands at $2.68 as of March 2025. Bristol Myers Squibb's EPS for 2023 stood at $3.88, a 30.6% increase from 2022.

BMY EPS growth

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

120.5%

EPS growth YoY

-213.7%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Bristol Myers Squibb has recorded an increase in EPS of 120.5% over the last 12 months (YoY, quarterly).

BMY Earnings Waterfall

Breakdown of revenue, profit and net income for Bristol Myers Squibb

BMY Earnings vs Peers

What are the earnings of BMY compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
MRK Merck & Co Inc	11.46	4,728.6%	9.4%	12%
PFE Pfizer Inc	16.8	273.7%	-28.7%	-13.2%
JNJ Johnson & Johnson	17.11	-57.9%	-9.7%	0.4%
ABT Abbott Laboratories	17.3	133.8%	24.5%	29.9%
BMY Bristol Myers Squibb Co	18.06	-213.7%	N/A	N/A
NVS Novartis AG	18.33	-17.2%	-17.9%	2.9%
AMGN Amgen Inc	26.27	-39.3%	-9.7%	-10.1%
AZN Astrazeneca plc	29.04	18.2%	284.3%	34.3%
LLY ELI LILLY & Co	62.39	102.1%	24.1%	5.7%
ABBV AbbVie Inc	80.44	-12.1%	-28.2%	-14.7%

All data is based on quarterly TTM periods, unless otherwise specified.